Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The use of IORT at Universitätsmedizin Mannheim hospital

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023

Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML

Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA
Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML ( Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA )
28 Apr 2023

Applying the syndemic framework to cancer research for effective cancer control in LMICs

Dr Zahid Butt - University of Waterloo, Waterloo, Canada
Applying the syndemic framework to cancer research for effective cancer control in LMICs ( Dr Zahid Butt - University of Waterloo, Waterloo, Canada )
27 Apr 2023

Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC

Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC ( Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia )
27 Apr 2023

Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC

Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC ( Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain )
26 Apr 2023

Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma

Prof Peter Szlosarek - Barts Cancer Institute, London, UK
Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma ( Prof Peter Szlosarek - Barts Cancer Institute, London, UK )
26 Apr 2023

The multidisciplinary team (MDT) approach and quality of care

Dr Ung Nearot - Calmette Hospital, Phnom Penh, Cambodia
The multidisciplinary team (MDT) approach and quality of care ( Dr Ung Nearot - Calmette Hospital, Phnom Penh, Cambodia )
26 Apr 2023

CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023

Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours

Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours ( Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA )
26 Apr 2023

Does the mind matter in cancer? Experiences of Psycho-oncology from a tertiary cancer centre in South Asia

Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Does the mind matter in cancer? Experiences of Psycho-oncology from a tertiary cancer centre in South Asia ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
25 Apr 2023

Challenge mission to improve access to quality cancer care

Thet Ko Aung - City Cancer Challenge, Yangon, Myanmar
Challenge mission to improve access to quality cancer care ( Thet Ko Aung - City Cancer Challenge, Yangon, Myanmar )
25 Apr 2023

Choosing Wisely: An important step in the right direction

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Choosing Wisely: An important step in the right direction ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
25 Apr 2023